Table 3.
Method and group | Result | No. of patients with a clinical diagnosis of MTB | Mean (%) | ||||
+ | − | Se | Sp | PPV | NPV | ||
SAT | |||||||
All | + | 146 | 0 | 66.7 | 100 | 100 | 34.2 |
− | 73 | 38 | |||||
Smear-positive | + | 103 | 0 | 93.6 | 100 | 100 | 36.4 |
− | 7 | 4 | |||||
Smear-negative | + | 43 | 0 | 39.4 | 100 | 100 | 34.0 |
− | 66 | 34 | |||||
BACTECTM MGITTM 960 culture | |||||||
All | + | 118 | 6 | 53.9 | 84.2 | 95.2 | 24.1 |
− | 101 | 32 | |||||
Smear-positive | + | 100 | 4 | 90.9 | 0 | 96.2 | 0 |
− | 10 | 0 | |||||
Smear-negative | + | 18 | 2 | 16.5 | 94.1 | 90.0 | 26.0 |
− | 91 | 32 |
MTB, Mycobacterium tuberculosis; NPV, negative predictive value; PPV, positive predictive value; SAT, simultaneous amplification and testing; Se, sensitivity; Sp, specificity.